News & AnalysisYemaachi Biotech fetches $3m seedYemaachi Biotech, a cancer research and diagnostics company, has raised $3 million in seed funding.ByIris Dorbian21 March 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs